Personalis Stock

Personalis Forward P/E

The Forward P/E Ratio of Personalis (PSNL) as of Aug 18, 2026 is -8.97. In the previous year, Forward P/E Ratio was -8.97 — a change of 0.02% (lower).

Forward P/E

-8.97

YoY

0.02%

Last updated:

Forward P/E Ratio of Personalis is 2026 -8.97 . Forward P/E Ratio of Personalis was 2025 -8.97 . It decreases by 0.02% lower compared to the previous year.
Access this data via the Eulerpool API

Personalis Stock analysis

What does Personalis do? Personalis Inc is a diagnostic company specializing in the development of tests for personalized medicine. The company was founded in 2011 by Dr. Richard Chen and Dr. Erin Newburn and is headquartered in Menlo Park, California. They initially focused on developing genomic tools for cancer diagnosis and treatment but have expanded their offerings to include tests for rare genetic diseases, immunotherapies, and precision oncology drugs. They work closely with pharmaceutical and biotechnology companies as well as academics to develop innovative therapeutic approaches. Their business model is based on making genomics biology usable for personalized medicine and clinical research. They have a wide portfolio of genomic-based solutions for personalized medicine, including tests for tumor mutations, tumor-specific neoantigens, rare genetic diseases, and personalized immunotherapy. They also offer customized genomic solutions for pharmaceutical and biotechnology companies. Personalis Inc aims to establish personalized medicine quickly and effectively to provide the best possible outcome for patients. Personalis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Personalis stock

Forward P/E Ratio of Personalis is -8.97 in 2026.

Forward P/E Ratio of Personalis changed from -8.97 to -8.97, representing a 0.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Personalis since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Personalis with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Personalis

All Key Metrics — Personalis